# CVE-2026-105177: SourceCodester Drug Recommendation System Drug Creation add_drug.php sql injection

> Remote attackers can exploit SQL injection in the drug creation module to read or modify database contents.

- **Severity:** Medium 5.1 (`CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P`)
- **Exploited in the wild:** Not known
- **Login needed:** An administrator
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 5 Oct 2026
- **Updated:** 5 Oct 2026
- **Also known as:** GHSA-46x6-gw8q-rwjw

## What is CVE-2026-105177?

CVE-2026-105177 is a medium-severity SQL injection vulnerability in SourceCodester Drug Recommendation System, published on 5 Oct 2026. An attacker needs administrator access to exploit it, with no action from the victim.

### Official description

A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. The affected element is an unknown function of the file /Admin/add_drug.php of the component Drug Creation. Such manipulation of the argument txtname/cmdtype/txtusage/txtsideeffect/cmdcontraindication leads to sql injection. The attack may be performed from remote. The exploit is publicly available and might be used.

Weakness: CWE-89 (Improper Neutralization of Special Elements used in an SQL Command), CWE-74 (Improper Neutralization of Special Elements in Output Used by a Downstream Component)

## Which versions are affected by CVE-2026-105177?


## How do I fix CVE-2026-105177?

No fix has been published for CVE-2026-105177 yet. Limit exposure of the affected software until one is available.

## Is CVE-2026-105177 being exploited?

There is no known exploitation of CVE-2026-105177 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2026-105177 and fix it if it is affected.

What it is: CVE-2026-105177 is a medium-severity SQL injection vulnerability in SourceCodester Drug Recommendation System, published on 5 Oct 2026. An attacker needs administrator access to exploit it, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2026-105177 in the wild and no public exploit code.

Affected product: SourceCodester Drug Recommendation System. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2026-105177/ (Markdown: https://insights.sbomify.com/CVE-2026-105177/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2026-105177
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2026-105177
- OSV: https://osv.dev/vulnerability/CVE-2026-105177

---
From sbomify Insights: https://insights.sbomify.com/CVE-2026-105177/
Summaries are generated and may contain mistakes; the official description above is the record.